A carregar...

RAF/MEK dependence of KRAS mutant pancreatic ductal adenocarcinomas

Studies employing genetically engineered mouse models indicate that RAF activation is sufficient to induce pancreas intraepithelial neoplasms (PanINs) suggesting that MEK inhibitor-based combination approaches may have clinical utility in patients with pancreatic ductal adenocarcinomas.

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Discov
Main Authors: Hanrahan, Aphrothiti J., Solit, David B.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5031078/
https://ncbi.nlm.nih.gov/pubmed/22886659
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-12-0308
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!